Xeomin 100 Unit (Incobotulinumtoxina POWDER FOR SOLUTION) 100 UNIT

XEOMIN 100 Unit is a powder for solution used for various therapeutic purposes. This product contains incobotulinumtoxinA and is administered intramuscularly. Learn more about its uses and effects.

Strength

100 UNIT

Manufacturer / TM Owner

MERZ PHARMACEUTICALS GMBH

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XEOMIN 100 Unit is primarily used for the treatment of muscle-related conditions. It is often employed for what is XEOMIN used for, including the reduction of muscle spasms and the management of certain neurological disorders. The powder is reconstituted into a solution and administered intramuscularly to achieve the desired therapeutic effects.

Side Effects

Common effects of XEOMIN 100 Unit may include temporary muscle weakness or paralysis in the treated area. Some individuals may experience localized pain, swelling, or bruising at the injection site. These effects are generally mild and transient, resolving within a few days to weeks.

Precautions & Warnings

XEOMIN 100 Unit should be handled with care and stored as per the manufacturer's instructions. It is important to follow the healthcare provider's guidelines for administration. Individuals with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

XEOMIN 100 Unit may interact with other medications, particularly those that affect muscle function or nerve transmission. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence the effects of XEOMIN.

Frequently Asked Questions

XEOMIN is used for the treatment of muscle-related conditions, including muscle spasms and certain neurological disorders.

XEOMIN is administered intramuscularly after reconstituting the powder into a solution.

Common side effects may include temporary muscle weakness, localized pain, swelling, or bruising at the injection site.

XEOMIN may interact with other medications, so it is important to consult your healthcare provider before combining it with other treatments.

XEOMIN should be stored according to the manufacturer's instructions to maintain its efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.